The National HIVQUAL Project

1
The National HIVQUAL Project

• A Look At National Performance Data
• 2002

2
Sample Characteristics - 2002

• 64 facilities submitted data
• 3420 patients in sample
• 20 states represented

3
Demographic VariablesClinic Type and Gender -
2002
4
Demographic VariablesRace/Ethnicity - 2002
5
Demographic VariablesExposure Category - 2002
6
National Patient Sample 2002Race/Ethnicity

7
National Patient Sample 2002Age
8
National Patient Sample 2002Exposure Category
9
National Patient Sample 2002Gender
10
2002 Performance Data
11
CD4 Count Monitoring Every 4 Months
2002
12
CD4 Count Monitoring Within the Last 4 Months
2002
13
Viral Load Monitoring Every 4 Months
2002
14
Viral Load Monitoring Within the Last 4 Months
2002
15
ARV Management Stable Review Periods
N 3075
N 2738
N 1022
N 2580
N 2043
N 38
N 28
N 46
N 53
N 3276
N 801
N 1065
N 671
N 3320
N 2477
N 5813
2002
16
ARV Management Unstable Review Periods
N 759
N 595
N 217
N 631
N 441
N 18
N 10
N 6
N 30
N 695
N 172
N 336
N 151
N 743
N 610
N 1354
2002
17
ARV Management Patients Managed Appropriately
during All Trimesters
N 1456
N 1270
N 486
N 1231
N 915
N 20
N 15
N 20
N 37
N 1508
N 379
N 527
N 312
N 1545
N 1175
N 2726
2002
18
PPD Placed and Read
2002
19
Mental Health Assessment
2002
20
Pelvic Exam
2002
21
Longitudinal Data
22

• Title III IV Project Participants

2 Year Participants 23 3 Year
Participants 21 4 Year Participants 11 5
Year Participants 14 Not necessarily
consecutive years of participation
23
OI Prophylaxis Data
PCP PROPHYLAXIS
MAC PROPHYLAXIS
24
Pelvic Exam PPD Performance Data
PELVIC EXAMINATION
PPD SCREENING
PPD Placed and Read
25
VIRAL LOAD CD4 MONITORING
VIRAL LOAD MONITORING
CD4 COUNT MONITORING
CD4 Count 1998 2000 within last 6 months 2001
2002 within last 4 months
Viral Load Staging 1998 - 1999 within last 6
months 2000 - 2002 within last 4 months
26
VIRAL LOAD CD4 MONITORING
CD4 COUNT MONITORING
VIRAL LOAD STAGING
Viral Load Staging Every 4 Months
CD4 Count Every 4 Months
27
Clinic Visits
Clinic Visit Every 4 Months
28
STABLE 4-MONTH REVIEW PERIODS
ARV THERAPY MANAGEMENT
PATIENTS PRESCRIBED ARV THERAPY
UNSTABLE 4-MONTH REVIEW PERIODS
Therapy Managed Appropriately for All Review
Periods During 12 Months
Therapy Managed Appropriately
29
HAART THERAPY ACCESS TO HAART
30
National HIVQUAL Project
Total Patients Reviewed, by Indicator and Review
Period 14 Facilities Participating Each Year
31
National HIVQUAL Project
32
National HIVQUAL Project